Ink Marking, Epoxy Base. Catalyst Component

SECTION 2: Hazards identification

OSHA EMERGENCY OVERVIEW PHYSICAL APPEARANCE: Liquid As noted in the preface to published values adopted by the ACGIH TLV’s represent “conditions under which it is believed that nearly all workers may be repeatedly exposed day after day without adverse effect. Because of wide variation in individual susceptibility however, a small percentage of workers may experience discomfort from some substances at concentrations at or below the threshold limit, a smaller percentage may be affected more seriously by aggravation of pre-existing condition or by development of occupational illness”.

Potential health effects

EYES: May be corrosive to eyes and cause severe damage, including blindness. Vapors may also be irritating to eyes. SKIN: Moderately irritating. Sensitizer. Prolonged or widespread contact may lead to irritation, defatting, or dermatitis; absorption may lead to headache, drowsiness, nausea, breathing difficulties. INGESTION: Moderately irritating to gastrointestinal tract. Can cause headache, diarrhea, drowsiness, breathing difficulties, nausea, vomiting. INHALATION: Moderately irritating to nasal respiratory tracts. Can cause headache, drowsiness, dizziness, breathing difficulties, nausea, unconsciousness. CHRONIC: No chronic health concerns known. CARCINOGENICITY: Toluene Prop 65 Yes, IARC Grp 3, NTP No, OSHA No MUTAGENICITY: This material is not known to have mutagenic effects on genetic material. IRRITANCY: This material may cause irritation to the eyes, skin, and respiratory tract. Use correct PPE when handling this material. REPRODUCTIVE TOXICIITY REPRODUCTIVE EFFECTS: This material is not known to cause any reproductive system damage.

Teratogenic Effects

This material is not known to contain any teratogenic substances 3. COMPOSITION/CHEMICAL INFORMATION Chemical Name CAS Number Weight % *N Butyl Alcohol 71-36-3 5-15 *Toluene 108-88-3 2-5 *Glycol Ether PM 107-98-2 2-5 **Mixture, Proprietary Mixture * Toxic chemical subject to the reporting requirements of section 313 of Title III and of 40 CFR 372. **In the event of a medical emergency ; specific chemical information will be made available to treating physician or nurse.